Literature DB >> 21193435

Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis.

Hirokuni Akahori1, Takeshi Tsujino, Yoshiro Naito, Mika Matsumoto, Masaaki Lee-Kawabata, Mitsumasa Ohyanagi, Masataka Mitsuno, Yuji Miyamoto, Takashi Daimon, Hiroyuki Hao, Seiichi Hirota, Tohru Masuyama.   

Abstract

AIMS: The haemorrhage in the plaque (intraplaque haemorrhage) plays a critical role in the progression of atherosclerosis. The purpose of this study is to clarify whether the haemorrhage in the aortic valve leaflet (intraleaflet haemorrhage) accelerates the progression of aortic valve stenosis (AS). METHODS AND
RESULTS: We examined specimens of aortic valve leaflets obtained from 36 patients who had undergone aortic valve replacement for degenerative AS and in whom echocardiographic data were available just before the operation and at least 180 days before the last study. The stenotic valves were examined by immunohistochemistry to detect intraleaflet haemorrhage with antibody against glycophorin A, an erythrocyte-specific protein. The progression of AS was assessed by annualized change in the aortic valve area (ΔAVA: cm(2)/year). The patients were divided into two groups, namely the rapid progression group (ΔAVA ≥ 0.1 cm(2)/year) and the slow progression group (ΔAVA < 0.1 cm(2)/year), according to the reported average progression rate of AS. Intraleaflet haemorrhage was observed in 78 % of the specimens. Intraleaflet haemorrhage was associated with neovascularization and macrophage infiltration. The areas of intraleaflet haemorrhage and macrophage infiltration were greater in the rapid progression group than in the slow progression group. Multivariate analysis has shown that the area of intraleaflet haemorrhage was the sole independent factor that positively correlated with ΔAVA.
CONCLUSIONS: Intraleaflet haemorrhage was frequently observed in the valve leaflets of degenerative AS and associated with a rapid progression of AS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193435     DOI: 10.1093/eurheartj/ehq479

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

2.  Valvular heart disease in the elderly: more questions than answers.

Authors:  Sean Coffey; Bernard Prendergast
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

Review 3.  Large animal models of cardiovascular disease.

Authors:  H G Tsang; N A Rashdan; C B A Whitelaw; B M Corcoran; K M Summers; V E MacRae
Journal:  Cell Biochem Funct       Date:  2016-02-24       Impact factor: 3.685

4.  Is bioprosthetic leaflet thrombosis a trigger to valve degeneration?

Authors:  Mhairi Katrina Doris; Marc Richard Dweck
Journal:  Heart       Date:  2018-03-01       Impact factor: 5.994

Review 5.  Red Blood Cells and Hemoglobin in Human Atherosclerosis and Related Arterial Diseases.

Authors:  Jean-Baptiste Michel; José Luis Martin-Ventura
Journal:  Int J Mol Sci       Date:  2020-09-15       Impact factor: 5.923

6.  Colocalization of Erythrocytes and Vascular Calcification in Human Atherosclerosis: A Systematic Histomorphometric Analysis.

Authors:  Elsa Wilma Böhm; Maria Pavlaki; Georgios Chalikias; Dimitrios Mikroulis; George S Georgiadis; Dimitrios N Tziakas; Stavros Konstantinides; Katrin Schäfer
Journal:  TH Open       Date:  2021-04-14

7.  Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis.

Authors:  Andres Laguna-Fernandez; Miguel Carracedo; Gregoire Jeanson; Edit Nagy; Per Eriksson; Giuseppina Caligiuri; Anders Franco-Cereceda; Magnus Bäck
Journal:  Eur Heart J       Date:  2016-04-18       Impact factor: 29.983

Review 8.  Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment.

Authors:  Rita Kleinauskienė; Regina Jonkaitienė
Journal:  Medicina (Kaunas)       Date:  2018-04-25       Impact factor: 2.430

9.  Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences.

Authors:  Alexander Kostyunin; Rinat Mukhamadiyarov; Tatiana Glushkova; Leo Bogdanov; Daria Shishkova; Nikolay Osyaev; Evgeniy Ovcharenko; Anton Kutikhin
Journal:  Int J Mol Sci       Date:  2020-10-09       Impact factor: 5.923

10.  Degeneration of Bioprosthetic Heart Valves: Update 2020.

Authors:  Alexander E Kostyunin; Arseniy E Yuzhalin; Maria A Rezvova; Evgeniy A Ovcharenko; Tatiana V Glushkova; Anton G Kutikhin
Journal:  J Am Heart Assoc       Date:  2020-09-21       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.